Evolus Inc (EOLS)
13.04
+0.41
(+3.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.05
+0.01
(+0.08%)
After-Hours: 20:00
Evolus Gross Profit Margin (Quarterly): 70.17% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 70.17% |
| June 30, 2024 | 71.49% |
| March 31, 2024 | 69.55% |
| December 31, 2023 | 68.41% |
| September 30, 2023 | 69.15% |
| June 30, 2023 | 70.19% |
| March 31, 2023 | 70.89% |
| December 31, 2022 | 69.37% |
| September 30, 2022 | 60.21% |
| June 30, 2022 | 57.43% |
| March 31, 2022 | 61.05% |
| Date | Value |
|---|---|
| December 31, 2021 | 54.31% |
| September 30, 2021 | 56.93% |
| June 30, 2021 | 56.69% |
| March 31, 2021 | 59.91% |
| December 31, 2020 | 64.63% |
| September 30, 2020 | 72.52% |
| June 30, 2020 | 75.04% |
| March 31, 2020 | 59.80% |
| December 31, 2019 | 81.30% |
| September 30, 2019 | 71.76% |
| June 30, 2019 | 71.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
54.31%
Minimum
Dec 2021
81.30%
Maximum
Dec 2019
65.95%
Average
68.78%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Insulet Corp | 69.33% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 78.34% |
| Xtant Medical Holdings Inc | 58.37% |
| Myomo Inc | 75.43% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.72K% |
| Return on Assets | -26.50% |
| Return on Invested Capital | -47.66% |
| Profit Margin (Quarterly) | -31.38% |
| Operating Margin (Quarterly) | -21.36% |
| Return on Net Operating Assets | -42.24% |